Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
6185.HK Stock Summary
Top 10 Correlated ETFs
6185.HK
In the News
6185.HK Financial details
Company Rating
Buy
Market Cap
12.34B
Income
-275.76M
Revenue
6.03M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
1.95K
Optionable
No
Shortable
Yes
Earnings
30 Aug 2023
P/E
-5.82
Forward P/E
490
PEG
0.56
P/S
11.49
P/B
0.83
P/C
-
P/FCF
-4
Quick Ratio
2.02
Current Ratio
2.63
Debt / Equity
0.4
LT Debt / Equity
0.16
-
-
EPS (TTM)
-0.34
EPS next Y
0.05
EPS next Q
-
EPS this Y
-150.52%
EPS next Y
-115.6%
EPS next 5Y
-115.6%
EPS last 5Y
44.07%
Revenue last 5Y
290.74%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
1.08%
SMA50
-6.81%
SMA100
-32.96%
Inst Own
0%
Inst Trans
0%
ROA
-8%
ROE
-13%
ROC
-0.16%
Gross Margin
-18%
Oper. Margin
-133%
Profit Margin
-94%
Payout
-20%
Shs Outstand
521.1M
Shs Float
128.55M
-
-
-
-
Target Price
-
52W Range
22.2-147.5
52W High
-83.33%
52W Low
+11.36%
RSI
49.89
Rel Volume
0.06
Avg Volume
2.5M
Volume
155.37K
Perf Week
1.66%
Perf Month
-3.54%
Perf Quarter
-40.89%
Perf Half Y
-45.74%
-
-
-
-
Beta
0.678662
-
-
Volatility
0.58%, 0.66%
Prev Close
-2%
Price
24.5
Change
-1.8%
6185.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 0.01 | 0.01 | 0.08 | 17.38 | 4.17 | |
Net income per share | -0.63 | -0.75 | -1.55 | 7.74 | -3.91 | |
Operating cash flow per share | -0.57 | -0.84 | -2.03 | 8.14 | -7.64 | |
Free cash flow per share | -1.3 | -1.41 | -3.21 | 3.28 | -11.99 | |
Cash per share | 0.9 | 3.71 | 22.15 | 31.45 | 24.07 | |
Book value per share | 2.3 | 7.23 | 26.29 | 32.31 | 27.32 | |
Tangible book value per share | 2.07 | 6.95 | 25.98 | 33.74 | 28.28 | |
Share holders equity per share | 2.3 | 7.23 | 26.29 | 32.31 | 27.32 | |
Interest debt per share | 0.69 | 0.82 | 0.62 | 5.64 | 11.1 | |
Market cap | 6.59B | 10.7B | 34.19B | 36.39B | 14.71B | |
Enterprise value | 6.69B | 10.66B | 29.89B | 32.31B | 14.01B | |
P/E ratio | -47.68 | -69.87 | -95.38 | 19.01 | -15.24 | |
Price to sales ratio | 5.82K | 4.68K | 1.84K | 8.46 | 14.26 | |
POCF ratio | -53.32 | -62.86 | -72.85 | 18.06 | -7.79 | |
PFCF ratio | -23.19 | -37.26 | -46.2 | 44.85 | -4.96 | |
P/B Ratio | 13.13 | 7.27 | 5.63 | 4.55 | 2.18 | |
PTB ratio | 13.13 | 7.27 | 5.63 | 4.55 | 2.18 | |
EV to sales | 5.91K | 4.67K | 1.61K | 7.51 | 13.59 | |
Enterprise value over EBITDA | -48.17 | -77.29 | -74.17 | 16.34 | -13.61 | |
EV to operating cash flow | -54.07 | -62.65 | -63.68 | 16.04 | -7.42 | |
EV to free cash flow | -23.51 | -37.13 | -40.38 | 39.82 | -4.73 | |
Earnings yield | -0.02 | -0.01 | -0.01 | 0.05 | -0.07 | |
Free cash flow yield | -0.04 | -0.03 | -0.02 | 0.02 | -0.2 | |
Debt to equity | 0.3 | 0.11 | 0.02 | 0.17 | 0.4 | |
Debt to assets | 0.19 | 0.09 | 0.02 | 0.12 | 0.24 | |
Net debt to EBITDA | -0.67 | 0.26 | 10.68 | -2.06 | 0.67 | |
Current ratio | 2.07 | 6.39 | 13.13 | 3.23 | 2.63 | |
Interest coverage | 0 | 0 | 0 | 93.62 | -33.11 | |
Income quality | 0.89 | 1.09 | 1.15 | 1.06 | 1.59 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0.01 | |
Payout ratio | -0.05 | -0.06 | 0 | 0 | -0.2 | |
Sales general and administrative to revenue | 18.2 | 27.5 | 4.47 | 0.05 | 0.27 | |
Research and developement to revenue | 100.39 | 66.46 | 23.11 | 0.2 | 0.75 | |
Intangibles to total assets | 0.06 | 0.03 | 0.01 | 0.02 | 0.02 | |
Capex to operating cash flow | 1.3 | 0.69 | 0.58 | -0.6 | 0.57 | |
Capex to revenue | -141.94 | -51.22 | -14.6 | -0.28 | -1.04 | |
Capex to depreciation | -13.37 | -5.2 | -8.51 | -13.59 | -5.47 | |
Stock based compensation to revenue | 13.94 | 9.42 | 0.94 | 0 | 0.01 | |
Graham number | 5.73 | 11.06 | 30.3 | 74.99 | 49 | |
ROIC | -0.19 | -0.12 | -0.06 | 0.2 | -0.12 | |
Return on tangible assets | -0.19 | -0.09 | -0.05 | 0.16 | -0.09 | |
Graham Net | -0.89 | 2.27 | 19.58 | 19.78 | 8.35 | |
Working capital | 114.32M | 669.95M | 5.01B | 6.41B | 4.79B | |
Tangible asset value | 451.06M | 1.41B | 6B | 8.35B | 6.99B | |
Net current asset value | -72.55M | 480.26M | 4.74B | 5.96B | 3.51B | |
Invested capital | 0.3 | 0.11 | 0.02 | 0.17 | 0.4 | |
Average receivables | -201.16M | -58.82M | 8.95M | 0 | 0 | |
Average payables | 4.27M | 6.41M | 33.37M | 451.57M | 547.84M | |
Average inventory | 5.06M | 12.42M | 93.43M | 523.07M | 776.7M | |
Days sales outstanding | -43.71K | 2.86K | 0 | 0 | 0 | |
Days payables outstanding | 21.36 | 15.27K | 1.6K | 237.21 | 75.87 | |
Days of inventory on hand | 27.28 | 40.44K | 4.51K | 246.51 | 203.17 | |
Receivables turnover | -0.01 | 0.13 | 0 | 0 | 0 | |
Payables turnover | 17.09 | 0.02 | 0.23 | 1.54 | 4.81 | |
Inventory turnover | 13.38 | 0.01 | 0.08 | 1.48 | 1.8 | |
ROE | -0.28 | -0.1 | -0.06 | 0.24 | -0.14 | |
Capex per share | -0.74 | -0.57 | -1.17 | -4.86 | -4.35 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q4
Metric | History | 2020-12-31 | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | -4.3B | -3.59B | -4.08B | -1.62B | -694.19M | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.02 | 0.13 | 0.17 | 0.28 | 0.4 | |
Debt to assets | 0.02 | 0.09 | 0.12 | 0.18 | 0.24 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 13.13 | 2.92 | 3.23 | 2.99 | 2.63 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 5.01B | 5.41B | 6.41B | 5.99B | 4.79B | |
Tangible asset value | 6B | 6.92B | 8.35B | 8.14B | 6.99B | |
Net current asset value | 4.74B | 4.99B | 5.96B | 5.27B | 3.51B | |
Invested capital | 0.02 | 0.13 | 0.17 | 0.28 | 0.4 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 35.42M | 0 | 0 | 0 | 0 | |
Average inventory | 115.74M | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
6185.HK Frequently Asked Questions
What is CanSino Biologics Inc. stock symbol ?
CanSino Biologics Inc. is a CN stock and trading under the symbol 6185.HK
What is CanSino Biologics Inc. stock quote today ?
CanSino Biologics Inc. stock price is $24.5 today.
Is CanSino Biologics Inc. stock public?
Yes, CanSino Biologics Inc. is a publicly traded company.